Key result
Female sex linked to ~33% higher coronary blood flow and lower major cardiovascular events rates versus males.
Why the study?
Clinically manifest CAD in women is delayed by up to 2 decades compared with men without a defined physiological basis.
Are there sex differences in quantitative coronary blood flow and clinical outcomes among patients in the CENTURY trial?
RCT (n=1,028)
Randomized
Are there sex differences in quantitative coronary blood flow and clinical outcomes among patients in the CENTURY trial?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“These findings suggest potential, hypothetical new mechanisms for the delayed onset and reduced severity of CAD in women. A sex-specific physiological-fluid dynamic anatomical configuration of the female coronary tree – smaller arteries with higher CBF, generating diffuse antiatherogenic ESS established during childhood – may be a primary mechanism contributing to lifelong reduction in CAD relative to men and to the estrogen paradox.”
Women have significantly higher rest and stress coronary blood flow compared to men, which may contribute to higher antiatherogenic endothelial shear stress and delayed onset of clinically manifest coronary artery disease.
BACKGROUND: Despite comparable cardiovascular risk factors, clinically manifest coronary artery disease (CAD) in women is delayed by up to 2 decades compared with men without a defined physiological basis. OBJECTIVES: This study aims to assess the mechanistic basis of sex differences in CAD using quantitative coronary blood flow (CBF) and coronary flow capacity measured by positron emission tomography in a post hoc analysis of the randomized CENTURY trial. METHODS: CENTURY trial data were reanalyzed in 331 women vs 697 men for risk factors, age, quantitative CBF, coronary flow capacity, and clinical outcomes through 14 years of follow-up. RESULTS: Women and men had similar age, body mass index, hypertension, diabetes, and cumulative summed risk scores. Still, women had less established CAD, lower coronary artery calcium, and fewer positron emission tomography perfusion defects. Women had approximately half the rates of all-cause death (log-rank P = 0.0223), death or myocardial infarction (log-rank P = 0.0138), revascularization (log-rank P = 0.0004), and major adverse cardiac events (log-rank P < 0.0001) compared with men by Kaplan-Meier plots. Rest and stress CBF were 33% higher in women than in men across all comparable strata of age, body mass index, risk factors, and treatment. When integrated with the published reports showing ∼10% smaller coronary arteries in women, these flow data suggest a potential global endothelial shear stress ∼82% higher in women than in men, suggesting a potential hypothetical chronic, diffuse, antiatherogenic differential mechanism. CONCLUSIONS: In the randomized CENTURY trial, women had higher CBF than men across all comparable strata. Combined with the smaller coronary arteries reported in the published reports, this higher CBF suggests a potential, hypothesized higher antiatherogenic ESS that may be a primary, sex-specific physiological mechanism underlying the delayed onset and modifying the course of CAD throughout women's lives. (Comprehensive LifEstyle ModificatioN, Optimal Pharmacological Treatment and Utilizing PET Imaging for Quantifying and Managing Stable CoronaRy ArterY Disease [CENTURY]; NCT00756379).
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Gould et al. (2026) conducted an RCT in Coronary artery disease (n=1,028). Female sex vs. Male sex was evaluated on Major adverse cardiac events (p=<0.0001). Female sex was associated with 33% higher rest and stress coronary blood flow and lower rates of major adverse cardiac events compared with male sex.
Synapse has enriched 10 related papers. Consider them for comparative context: